Bronchial hyperresponsiveness as a phenotypic feature of chronic obstructive pulmonary disease (original) (raw)

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (19)

  1. Hospers J.J., Postma D.S., Rijcken B. et al. Histamine airway hyper responsiveness and mortality from chronic obstruc tive pulmonary disease: a cohort study. Lancet 2000; 356: 1313-1317.
  2. Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstruc tive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 1791-1797.
  3. Agust A., Noguera A., Sauleda J. et al. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 347-360.
  4. Wouters E.F. COPD: from an organ to a disease oriented approach. COPD 2008; 5 (2): 73-74.
  5. Agusti A. COPD, a multicomponent disease: implications for management. Respir. Med. 2005; 99: 670-682.
  6. Burgel P. R., Paillasseur J.L., Caillaud D. et al. Clinical COPD phenotypes: a novel approach using principal com ponent and cluster analyses. Eur. Respir. J. 2010; 36: 531-539.
  7. Han M.K., Agusti A., Calverley P.M. et al. COPD pheno types: The future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598-604.
  8. Авдеев С.Н. Фенотипы хронической обструктивной бо лезни легких: особенности терапии. Consilium medicum 2010; прилож.: 23-28.
  9. Garsia Aymerich J., Agusti A., Barbera J.A. et al. Phenotypic heterogenetiy of chronic obstructive pulmonary disease. Arch. Broncopneumol. 2009; 45: 133-142.
  10. Gulsvik A., Refvem O.K. Ascoring system on respiratory symptoms. Eur. Respir. J. 1988; 1: 428-432.
  11. Чучалин А.Г. (ред.). Стандартизация легочных функ циональных тестов. Пер. с англ. М.; 1993.
  12. Kanner R.E., Connett J.E., Altose M.D. et al. Gender differ ence in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am. J. Respir. Crit. Care Med. 1994; 150 (4): 956-961.
  13. Brutsche M.H., Downs S.H., Schindler C. et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006; 61: 671-677.
  14. Grootendorst D.C., Rabe K.F. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pul monary disease. Proc. Am. Thorac. Soc. 2004; 1: 77-87.
  15. Khaodhiar L., Ling P.R., Blackburn G.L. et al. Serum levels of interleukin 6 and C reactive protein correlate with body mass index across the broad range of obesity. J. Parenter. Enter. Nutr. 2004; 28 (6): 410-415.
  16. Bahceci M., Gokalp D., Bahceci S. et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin 6 and high sensitivity C reactive protein levels. Is adipocyte size associated with inflammation in adults? J. Endocrinol. Invest. 2007; 30 (3): 210-214.
  17. Xu X., Rijcken B., Schouten J.P. et al. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431-1434.
  18. Leuppi J.D., Tandjung R., Anderson S.D. et al. Prediction of treatment response to inhaled corticosteroids by mannitol challenge test in COPD. A proof of concept. Pulm. Pharmacol. Ther. 2005; 18 (2): 83-88.
  19. Информация об авторах Трофименко Ирина Николаевна -к. м. н., ассистент кафедры аллерго логии и пульмонологии Иркутского ГИУВ; тел.: 8 914 877 80 96, e mail: tin11@mail.ru Черняк Борис Анатольевич -д. м. н., проф., зав. кафедрой аллерголо гии и пульмонологии Иркутского ГИУВ; тел.: 8 902 568 78 70; e mail: bores@angara.ru